Overall, females carrying pathogenic FTD variants in MAPT, GRN, or C9orf72 presented with higher baseline plasma NfL concentrations and faster longitudinal increases of plasma NfL, an indicator of neuroaxonal degeneration, compared to males—particularly in later stages of disease. This evidence concerns the gene MAPT and frontotemporal dementia.